Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in Left Ventricular Thrombus after STEMI
IRCT20181022041406N4Phase 3Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rivaroxaban in Left ventricular thrombosis (LVT) and myocardial infarction (MI), sponsored by Rajaie Cardiovascular Medical and Research Center. Started Jun 2020; status: completed.
02
Drugs
rivaroxaban
03
Conditions
Left ventricular thrombosis (LVT)myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20181022041406N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181022041406N4.